← FDA Drug Approvals (Drugs@FDA)

XIFYRM

NDA · New Drug Application · Sponsor: AZURITY · Approved 2025-06-05

Drug application

FDA Application #

NDA218395

Application type

New Drug Application

Brand name

XIFYRM

Generic name

MELOXICAM

Active ingredients

MELOXICAM

Dosage form

SOLUTION

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

AZURITY

Manufacturer

Azurity Pharmaceuticals, Inc.

First approval

2025-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown